387 related articles for article (PubMed ID: 27862856)
1. Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding.
Marot A; Trépo E; Doerig C; Schoepfer A; Moreno C; Deltenre P
Liver Int; 2017 May; 37(5):707-716. PubMed ID: 27862856
[TBL] [Abstract][Full Text] [Related]
2. [Transient elastography as a predictor of oesophageal varices in patients with liver cirrhosis].
Pár G; Trosits A; Pakodi F; Szabó I; Czimmer J; Illés A; Gódi S; Bajor J; Sarlós P; Kenyeres P; Miseta A; Vincze A; Pár A
Orv Hetil; 2014 Feb; 155(7):270-6. PubMed ID: 24509356
[TBL] [Abstract][Full Text] [Related]
3. Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis.
Jangouk P; Turco L; De Oliveira A; Schepis F; Villa E; Garcia-Tsao G
Liver Int; 2017 Aug; 37(8):1177-1183. PubMed ID: 28160373
[TBL] [Abstract][Full Text] [Related]
4. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.
Lee HA; Kim SU; Seo YS; Lee YS; Kang SH; Jung YK; Kim MY; Kim JH; Kim SG; Suk KT; Jung SW; Jang JY; An H; Yim HJ; Um SH
Liver Int; 2019 Jun; 39(6):1071-1079. PubMed ID: 30589490
[TBL] [Abstract][Full Text] [Related]
6. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive diagnosis of esophageal varices after Baveno VI.
Moctezuma Velázquez C; Abraldes JG
Turk J Gastroenterol; 2017 May; 28(3):159-165. PubMed ID: 28492370
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
Maurice JB; Brodkin E; Arnold F; Navaratnam A; Paine H; Khawar S; Dhar A; Patch D; O'Beirne J; Mookerjee R; Pinzani M; Tsochatzis E; Westbrook RH
J Hepatol; 2016 Nov; 65(5):899-905. PubMed ID: 27388923
[TBL] [Abstract][Full Text] [Related]
10. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
[TBL] [Abstract][Full Text] [Related]
11. Liver stiffness plus platelet count can be used to exclude high-risk oesophageal varices.
Ding NS; Nguyen T; Iser DM; Hong T; Flanagan E; Wong A; Luiz L; Tan JY; Fulforth J; Holmes J; Ryan M; Bell SJ; Desmond PV; Roberts SK; Lubel J; Kemp W; Thompson AJ
Liver Int; 2016 Feb; 36(2):240-5. PubMed ID: 26212020
[TBL] [Abstract][Full Text] [Related]
12. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
Zhou H; Long J; Hu H; Tian CY; Lin SD
World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
[TBL] [Abstract][Full Text] [Related]
13. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
Gaete MI; Díaz LA; Arenas A; González K; Cattaneo M; Fuster F; Henríquez R; Soza A; Arrese M; Barrera F; Arab JP; Benítez C
Liver Int; 2020 Jun; 40(6):1427-1434. PubMed ID: 31916360
[TBL] [Abstract][Full Text] [Related]
14. Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.
Colli A; Gana JC; Yap J; Adams-Webber T; Rashkovan N; Ling SC; Casazza G
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD008759. PubMed ID: 28444987
[TBL] [Abstract][Full Text] [Related]
15. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
[TBL] [Abstract][Full Text] [Related]
16. Modified spleen stiffness measurement by transient elastography is associated with presence of large oesophageal varices in patients with compensated hepatitis C virus cirrhosis.
Calvaruso V; Bronte F; Conte E; Simone F; Craxì A; Di Marco V
J Viral Hepat; 2013 Dec; 20(12):867-74. PubMed ID: 24304456
[TBL] [Abstract][Full Text] [Related]
17. Screening for esophageal varices in cirrhotic patients - Non-invasive methods.
Mattos ÂZ; Schacher FC; John Neto G; Mattos AA
Ann Hepatol; 2019; 18(5):673-678. PubMed ID: 31279653
[TBL] [Abstract][Full Text] [Related]
18. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
[TBL] [Abstract][Full Text] [Related]
19. Transient elastography to rule out esophageal varices and portal hypertensive gastropathy in HIV-infected individuals with liver cirrhosis.
Montes Ramirez ML; Pascual-Pareja JF; Sánchez-Conde M; Bernardino De la Serna JI; Zamora Vargas FX; Miralles P; Castro JM; Ramírez M; Gutierrez I; Gonzalez-García J; Berenguer J; Arribas López JR
AIDS; 2012 Sep; 26(14):1807-12. PubMed ID: 22781218
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive laboratory, imaging and elastography markers in predicting varices with high risk of bleeding in cirrhotic patients.
Petrisor A; Stanescu AMA; Papacocea IR; Panaitescu E; Peagu R; Moldoveanu AC; Fierbinteanu-Braticevici C
Rom J Intern Med; 2021 Jun; 59(2):194-200. PubMed ID: 33544557
[No Abstract] [Full Text] [Related]
[Next] [New Search]